MAP2K7 and neoplasm: While average primary tumor size was not significantly changed by treatment with Peptide#3, the incidence of metastasis was significantly lower in nude mice that were treated with Peptide#3 compared to mice that were treated with the scrambled peptide or the MEK inhibitor PD184352.